Innovative Payments, Management are Needed for Cell and Gene Therapies
Cell and gene therapies are a transformative approach that provides new therapeutic options for patients with cancer, immune disorders, hemophilia, [...]
Reimbursing Innovative and Potentially Curative Gene and Cell Therapies
In this feature, following his participation in a workshop at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 Asia Pacific [...]
Can Economic Evaluation Achieve Meaningful Use in Reducing Healthcare Costs in the US?
Despite being the most inefficient in terms of healthcare spending among developed nations, the United States does not routinely apply [...]
Methodological Considerations in Economic Evaluations of Gene Therapies
Researchers recently performed a study aiming to identify methodological considerations in the research literature addressing economic evaluations (EEs) of gene [...]
Advertisement
